News

Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
US FDA approves gradual dosing for Lilly Alzheimer's drug
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
Food Dyes Are Lurking in Surprising Places
In addition to finding these dyes in brightly colored processed foods, the researchers also found them in more muted foods ...
STAT1d
Inside the staff exodus and tanking morale that threaten Makary’s FDA
The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s work, current ...
The FDA Just Launched an AI Tool That Could Change How Food Recalls Happen
The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...
After delay, Kalvista wins FDA OK for drug to treat rare swelling disorder
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
I Write About Food Recalls for a Living—Here's How to Find the Most Important Information on Your Product
In recalls, best-by or use-by dates are commonly provided. Even if the affected date has passed, be sure to check your ...
US FDA Approves KalVista's Oral Swelling Disorder Drug, Shares Rise
(Reuters) -KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first ...
ALS News Today1d
FDA grants orphan drug status to ALS gene therapy SNUG01
The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...